Chen H C, Hodgen G D, Matsuura S, Lin L J, Gross E, Reichert L E, Birken S, Canfield R E, Ross G T
Proc Natl Acad Sci U S A. 1976 Aug;73(8):2885-9. doi: 10.1073/pnas.73.8.2885.
Substances from urinary extracts of normal, nonpregnant subjects and human pituitary gonadotropin preparations were found to react similarly to human chorionic gonadotropin (hCG) in a radioimmunoassay system that is highly specific for hCG and without crossreactivity to human luteinizing hormone (hLH). The antiserum was produced in a rabbit immunized with a bovine albumin conjugate of the unique carboxyl-terminal peptide (residues 123-145) isolated from a tryptic digest of the reduced, S-carboxymethylated hCGbeta subunit. The antibody recognition site on the peptide was found to reside on the last 15 amino acid residues of the carboxyl-terminal peptide, as evidenced by the competitive binding activities against 125I-labeled hCG of a series of peptides chemically synthesized according to the carboxyl-terminal sequence of HCGbeta. In order to elucidate the nature of the crossreacting substance in urinary extracts, a human postmenopausal urinary preparation (Pergonal) and a kaolin-acetone extract of urine from a patient with Klinefelter's syndrome were subjected to gel chromatography on Sephadex G-100. The results indicate that fractions showing immunocrossreactivity with the antiserum to hCGbeta-carboxyl-terminal peptide coeluted with 125I-labeled hCG which was separated distinctly from hLH. The same fractions from this postmenopausal urinary gonadotropin preparation exhibited in vitro biological activity proportional to the immunocrossreactivity of the hCG-specific antiserum. Concentration of postmenopausal women's urine by acetone precipitation retained approximately five times more immunoreactivity per unit volume than kaolin-acetone extraction, when assayed with the antiserum to hCGbeta-carboxyl-terminal peptide.
在一种对人绒毛膜促性腺激素(hCG)具有高度特异性且与人促黄体生成素(hLH)无交叉反应的放射免疫分析系统中,发现正常非孕受试者尿液提取物中的物质以及人垂体促性腺激素制剂与hCG的反应相似。抗血清是在用从还原的、S - 羧甲基化的hCGβ亚基的胰蛋白酶消化物中分离出的独特羧基末端肽(残基123 - 145)的牛血清白蛋白缀合物免疫的兔子中产生的。肽上的抗体识别位点被发现位于羧基末端肽的最后15个氨基酸残基上,这一点通过根据HCGβ的羧基末端序列化学合成的一系列肽对125I标记的hCG的竞争性结合活性得到证明。为了阐明尿液提取物中交叉反应物质的性质,对人绝经后尿液制剂(普果那)和一名克兰费尔特综合征患者的尿液的高岭土 - 丙酮提取物进行了Sephadex G - 100凝胶色谱分析。结果表明,与抗hCGβ羧基末端肽血清表现出免疫交叉反应的级分与125I标记的hCG共洗脱,而125I标记的hCG与hLH明显分离。这种绝经后尿促性腺激素制剂的相同级分表现出与hCG特异性抗血清的免疫交叉反应成比例的体外生物活性。当用抗hCGβ羧基末端肽血清进行检测时,通过丙酮沉淀浓缩绝经后妇女尿液,每单位体积保留大约五倍于高岭土 - 丙酮提取的免疫反应性。